Trial intelligence / Profile preview

Bioequivalence study of rosuvastatin 10 mg in healthy volunteers

NL-OMON60845Phase 1Completed

Sponsor
Erasmus MC
Start
Oct 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 1 trial of rosuvastatin, sponsored by Erasmus MC. Started Oct 2024; status: completed.

02

Drugs

rosuvastatin

Beyond the preview

Go deeper on NL-OMON60845.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON60845.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call